financetom
Business
financetom
/
Business
/
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
Oct 13, 2025 11:31 AM

CHICAGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ( COSM ) ("Cosmos Health" or the “Company”) , a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $300,000 worth of Ethereum (ETH), increasing its total investment in ETH to $1.8 million.

This latest purchase was made under Cosmos Health’s previously announced $300 million digital assets facility, which supports the Company’s ongoing strategy to diversify its portfolio through strategic digital asset investments.

Greg Siokas, CEO of Cosmos Health ( COSM ), stated: “We have continued to increase our Ethereum holdings following last week’s purchase, bringing our total investment in ETH to $1.8 million. We remain committed to accelerating our acquisition program under our $300 million financing facility.”

About Cosmos Health Inc. ( COSM )

Cosmos Health Inc. ( COSM ) , incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health ( COSM ) also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health ( COSM ) has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, www.zipdoctor.co, www.cloudscreen.gr, as well as LinkedIn and X.

Forward-Looking Statements

With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise

Investor Relations Contact:

BDG Communications

[email protected]

Image: https://www.globenewswire.com/newsroom/ti?nf=OTU0NDYwMyM3MTkzMDkyIzIyOTgwOTQ=

Image: https://ml.globenewswire.com/media/NDAzMmE3ZGUtZWI0NS00MzBmLTlmZGMtZWEwMzEwNDRhM2U4LTEzMDk2NDQtMjAyNS0xMC0xMy1lbg==/tiny/Cosmos-Health-Inc-.png Image: Primary Logo

Source: Cosmos Health Inc. ( COSM )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Salesforce Shares Are Trading Higher Today: What You Need To Know
Salesforce Shares Are Trading Higher Today: What You Need To Know
Nov 9, 2024
Salesforce, Inc. ( CRM ) shares are trading higher Friday. The company revealed plans to hire over 1,000 employees to support the sales push for its new AI product, Agentforce, which targets the growing demand for AI-driven automation across various business functions. Here’s what you need to know. What To Know: According to Bloomberg, Agentforce is designed to help companies...
Packaging Corp Of America Insider Sold Shares Worth $15,995,683, According to a Recent SEC Filing
Packaging Corp Of America Insider Sold Shares Worth $15,995,683, According to a Recent SEC Filing
Nov 9, 2024
03:56 PM EST, 11/08/2024 (MT Newswires) -- Mark W Kowlzan, Director, Chairman & CEO, on November 06, 2024, sold 66,640 shares in Packaging Corp Of America ( PKG ) for $15,995,683. Following the Form 4 filing with the SEC, Kowlzan has control over a total of 445,337 shares of the company, with 423,475 shares held directly and 21,862 controlled indirectly....
Packaging Corp Of America Insider Sold Shares Worth $4,777,427, According to a Recent SEC Filing
Packaging Corp Of America Insider Sold Shares Worth $4,777,427, According to a Recent SEC Filing
Nov 9, 2024
03:52 PM EST, 11/08/2024 (MT Newswires) -- Thomas A Hassfurther, Executive Vice President, on November 06, 2024, sold 19,738 shares in Packaging Corp Of America ( PKG ) for $4,777,427. Following the Form 4 filing with the SEC, Hassfurther has control over a total of 279,867 shares of the company, with 180,038 shares held directly and 99,829 controlled indirectly. SEC...
What's Going On With Palantir Stock This Week?
What's Going On With Palantir Stock This Week?
Nov 9, 2024
Palantir Technologies Inc. ( PLTR ) shares are trading higher Friday after climbing new highs during the week. Here’s what you need to know. The Details: On Monday, Palantir ( PLTR ) reported third-quarter revenue of $725.52 million, surpassing the $701.13 million estimate and earnings per share of 6 cents, beating expectations of 4 cents. Total revenue rose 30% year-over-year,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved